These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33437897)

  • 1. COVID-19 epidemic prediction and the impact of public health interventions: A review of COVID-19 epidemic models.
    Xiang Y; Jia Y; Chen L; Guo L; Shu B; Long E
    Infect Dis Model; 2021; 6():324-342. PubMed ID: 33437897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on assessing early epidemiological parameters of COVID-19 epidemic in China].
    Song QQ; Zhao H; Fang LQ; Liu W; Zheng C; Zhang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Apr; 41(4):461-465. PubMed ID: 32113196
    [No Abstract]   [Full Text] [Related]  

  • 3. Mathematical modeling of COVID-19 transmission: the roles of intervention strategies and lockdown.
    Bugalia S; Bajiya VP; Tripathi JP; Li MT; Sun GQ
    Math Biosci Eng; 2020 Sep; 17(5):5961-5986. PubMed ID: 33120585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new SEAIRD pandemic prediction model with clinical and epidemiological data analysis on COVID-19 outbreak.
    Liu XX; Fong SJ; Dey N; Crespo RG; Herrera-Viedma E
    Appl Intell (Dordr); 2021; 51(7):4162-4198. PubMed ID: 34764574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Epidemiological Model Considering Isolation to Predict COVID-19 Trends in Tokyo, Japan: Numerical Analysis.
    Utamura M; Koizumi M; Kirikami S
    JMIR Public Health Surveill; 2020 Dec; 6(4):e23624. PubMed ID: 33259325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 epidemic and public health interventions in Shanghai, China: Statistical analysis of transmission, correlation and conversion.
    Yi D; Chen X; Wang H; Song Q; Zhang L; Li P; Ye W; Chen J; Li F; Yi D; Wu Y
    Front Public Health; 2022; 10():1076248. PubMed ID: 36703835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling study.
    Zhu W; Zhang M; Pan J; Yao Y; Wang W
    BMC Med; 2021 Dec; 19(1):308. PubMed ID: 34872559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological Investigation of the First 135 COVID-19 Cases in Brunei: Implications for Surveillance, Control, and Travel Restrictions.
    Wong J; Chaw L; Koh WC; Alikhan MF; Jamaludin SA; Poh WWP; Naing L
    Am J Trop Med Hyg; 2020 Oct; 103(4):1608-1613. PubMed ID: 32815514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus disease 2019 epidemic prediction in Shanghai under the "dynamic zero-COVID policy" using time-dependent SEAIQR model.
    Ma Y; Xu S; An Q; Qin M; Li S; Lu K; Li J; Lei L; He L; Yu H; Xie J
    J Biosaf Biosecur; 2022 Dec; 4(2):105-113. PubMed ID: 35756701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scenario prediction of public health emergencies using infectious disease dynamics model and dynamic Bayes.
    Gao S; Wang H
    Future Gener Comput Syst; 2022 Feb; 127():334-346. PubMed ID: 34566221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling and tracking Covid-19 cases using Big Data analytics on HPCC system platformm.
    Villanustre F; Chala A; Dev R; Xu L; LexisNexis JS; Furht B; Khoshgoftaar T
    J Big Data; 2021; 8(1):33. PubMed ID: 33614394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Course of disease and related epidemiological parameters of COVID-19: a prospective study based on contact tracing cohort].
    Zhou Y; Liang WJ; Chen ZH; Liu T; Song T; Chen SW; Wang P; Li JL; Lan YH; Cheng MJ; Huang JX; Niu JW; Xiao JP; Hu JX; Lin LF; Huang Q; Deng AP; Tan XH; Kang M; Chen GM; Dong MR; Zhong HJ; Ma W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Apr; 56(4):474-478. PubMed ID: 35488546
    [No Abstract]   [Full Text] [Related]  

  • 15. Modelling COVID-19 epidemic with confirmed cases-driven contact tracing quarantine.
    Wu F; Liang X; Lei J
    Infect Dis Model; 2023 Jun; 8(2):415-426. PubMed ID: 37082109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Tool for Real-time Estimation of Epidemiological Parameters of Communicable Diseases Using Contact-Tracing Data: Development and Deployment.
    Silenou BC; Verset C; Kaburi BB; Leuci O; Ghozzi S; Duboudin C; Krause G
    JMIR Public Health Surveill; 2022 May; 8(5):e34438. PubMed ID: 35486812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): A well-mixed SEIR model analysis.
    Hou C; Chen J; Zhou Y; Hua L; Yuan J; He S; Guo Y; Zhang S; Jia Q; Zhao C; Zhang J; Xu G; Jia E
    J Med Virol; 2020 Jul; 92(7):841-848. PubMed ID: 32243599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of isolation measures for epidemic control of COVID-19.
    Huang B; Zhu Y; Gao Y; Zeng G; Zhang J; Liu J; Liu L
    Appl Intell (Dordr); 2021; 51(5):3074-3085. PubMed ID: 34764586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
    Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission dynamics and successful control measures of SARS-CoV-2 in the mega-size city of Guangzhou, China.
    Zhao H; Zhang Z; Lun W; Chen Z; Lu X; Li J; Qiu F; Li S; Mao C; Lu Y; Chen J; He Q; Lu J; Yang Z
    Medicine (Baltimore); 2021 Dec; 100(48):e27846. PubMed ID: 35049185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.